Gilead Sciences, Inc. (OQ:GILD)

Business Focus: Bio Therapeutic Drugs

Recent Price for GILD
USD 83.270 +0.650 (+0.787%)
NSQ Delayed 15 minutes
Sep 22 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
83.370 86.267 9.04 5,654,657 108,744.48
1-Day Low 52-Week Low Yield Avg. Volume  
82.010 63.759 2.5% 11,111,178  

Latest 10 SEC filings (by transaction date) for GILD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,750  
Sep 11/17 Sep 7/17 Washington Robin L Indirect Ownership Common Stock S - Open market or private sale -18,070 $85.00
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Common Stock S - Open market or private sale -33,750 $85.00
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,750 $24.30
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -73,333  
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock S - Open market or private sale -14,995 $83.43
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock S - Open market or private sale -58,338 $83.03
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 73,333 $21.58
Sep 6/17 Sep 1/17 Alton Gregg H Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -17,250  
Sep 6/17 Sep 1/17 Alton Gregg H Direct Ownership Common Stock S - Open market or private sale -3,737 $83.54
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for GILD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -33,750  
Sep 11/17 Sep 7/17 Washington Robin L Indirect Ownership Common Stock S - Open market or private sale -18,070 $85.00
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Common Stock S - Open market or private sale -33,750 $85.00
Sep 11/17 Sep 7/17 Washington Robin L Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 33,750 $24.30
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -73,333  
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock S - Open market or private sale -14,995 $83.43
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock S - Open market or private sale -58,338 $83.03
Sep 6/17 Sep 1/17 Martin John C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 73,333 $21.58
Sep 6/17 Aug 31/17 Martin John C Direct Ownership Common Stock G - Gift -129,870  
Sep 6/17 Sep 1/17 Alton Gregg H Direct Ownership Non-qualified Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -17,250  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $GILD

StockTwits